Novel patient derived colorectal cancer organoid platform for automated high throughput drug discovery applications

被引:0
|
作者
Lim, A. [1 ]
Tong, Z. [1 ]
Fraser, E. [2 ]
Durban, V. [2 ]
Macha, P. [1 ]
Buddhikot, O. [1 ]
Baranowski, T. [1 ]
Baade, J. [1 ]
Katiyar, A. [1 ]
Amijee, H. [2 ]
Sirenko, O. [1 ]
机构
[1] Mol Devices, San Jose, CA USA
[2] Cellesce Biotechnol, Cardiff, Wales
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
B236/P1229
引用
收藏
页码:139 / 140
页数:2
相关论文
共 50 条
  • [1] Novel platform for automation of high throughput drug discovery using patient derived colorectal cancer organoids
    Lim, Angeline
    Tong, Zhisong
    Macha, Prathyushakrishna
    Sirenkp, Oksana
    CANCER RESEARCH, 2023, 83 (07)
  • [2] HTPS flow cytometry: A novel platform for automated high throughput drug discovery and characterization
    Edwards, BS
    Kuckuck, FW
    Prossnitz, ER
    Ransom, JT
    Sklar, LA
    JOURNAL OF BIOMOLECULAR SCREENING, 2001, 6 (02) : 83 - 90
  • [3] Miniaturization and characterization of patient derived hepatocellular carcinoma tumor organoid cultures for cancer drug discovery applications
    Close, David A.
    Johnston, Paul A.
    SLAS DISCOVERY, 2025, 30
  • [4] Advancing a screening platform with panels of patient-derived organoid models for drug discovery and development
    Rapisarda, Annamaria
    Jones, Eric
    Hose, Curtis
    Harris, Erik
    Campbell, Petreena S.
    Ortiz, Mariaestela
    Connelly, John
    Mahashetty, Nanda
    Silvers, Thomas
    Davoudi, Zahra
    Brady, Penny Sellers
    Rohrer, Tiffany Nikirk
    Grams, Julie
    Martin, Karen
    Ramsey, Patricia
    Bowles, Lori
    Britt, John R.
    Parchment, Ralph E.
    Dexheimer, Thomas S.
    Teicher, Beverly A.
    Doroshow, James H.
    Coussens, Nathan P.
    CANCER RESEARCH, 2023, 83 (07)
  • [5] A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
    Katrin P. Guillen
    Maihi Fujita
    Andrew J. Butterfield
    Sandra D. Scherer
    Matthew H. Bailey
    Zhengtao Chu
    Yoko S. DeRose
    Ling Zhao
    Emilio Cortes-Sanchez
    Chieh-Hsiang Yang
    Jennifer Toner
    Guoying Wang
    Yi Qiao
    Xiaomeng Huang
    Jeffery A. Greenland
    Jeffery M. Vahrenkamp
    David H. Lum
    Rachel E. Factor
    Edward W. Nelson
    Cindy B. Matsen
    Jane M. Poretta
    Regina Rosenthal
    Anna C. Beck
    Saundra S. Buys
    Christos Vaklavas
    John H. Ward
    Randy L. Jensen
    Kevin B. Jones
    Zheqi Li
    Steffi Oesterreich
    Lacey E. Dobrolecki
    Satya S. Pathi
    Xing Yi Woo
    Kristofer C. Berrett
    Mark E. Wadsworth
    Jeffrey H. Chuang
    Michael T. Lewis
    Gabor T. Marth
    Jason Gertz
    Katherine E. Varley
    Bryan E. Welm
    Alana L. Welm
    Nature Cancer, 2022, 3 : 232 - 250
  • [6] A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
    Guillen, Katrin P.
    Fujita, Maihi
    Butterfield, Andrew J.
    Scherer, Sandra D.
    Bailey, Matthew H.
    Chu, Zhengtao
    DeRose, Yoko S.
    Zhao, Ling
    Cortes-Sanchez, Emilio
    Yang, Chieh-Hsiang
    Toner, Jennifer
    Wang, Guoying
    Qiao, Yi
    Huang, Xiaomeng
    Greenland, Jeffery A.
    Vahrenkamp, Jeffery M.
    Lum, David H.
    Factor, Rachel E.
    Nelson, Edward W.
    Matsen, Cindy B.
    Poretta, Jane M.
    Rosenthal, Regina
    Beck, Anna C.
    Buys, Saundra S.
    Vaklavas, Christos
    Ward, John H.
    Jensen, Randy L.
    Jones, Kevin B.
    Li, Zheqi
    Oesterreich, Steffi
    Dobrolecki, Lacey E.
    Pathi, Satya S.
    Woo, Xing Yi
    Berrett, Kristofer C.
    Wadsworth, Mark E.
    Chuang, Jeffrey H.
    Lewis, Michael T.
    Marth, Gabor T.
    Gertz, Jason
    Varley, Katherine E.
    Welm, Bryan E.
    Welm, Alana L.
    NATURE CANCER, 2022, 3 (02) : 232 - +
  • [7] Development of automated 3D high-throughput drug screening platform for patient-derived breast cancer organoids
    Kim, Jungeun
    Kim, Hoe Suk
    Kim, Ga Yeon
    Park, Kyung Hyeun
    Ryu, Seung Yeon
    Lee, Sangeun
    Lee, Dong Woo
    Ku, Bosung
    Lee, Han-Byoel
    Han, Wonshik
    CANCER RESEARCH, 2022, 82 (04)
  • [8] Development of an automated platform for screening patient-derived organoid models
    Paul, Siddhartha
    Hose, Curtis
    Jones, Eric
    Harris, Erik
    Connelly, John
    Campbell, Petreena
    Ortiz, Mariaestela
    Dexheimer, Thomas S.
    Silvers, Thomas
    Brady, Penny Sellers
    Grams, Julie
    Rohrer, Tiffany Nikirk
    Martin, Karen
    Ramsey, Patricia
    Bowles, Lori
    Rapisarda, Annamaria
    Parchment, Ralph E.
    Teicher, Beverly A.
    Doroshow, James H.
    Coussens, Nathan P.
    CANCER RESEARCH, 2022, 82 (12)
  • [9] Patient-Derived Organoid Model in the Prediction of Chemotherapeutic Drug Response in Colorectal Cancer
    Hao, Minglu
    Cao, Zhipeng
    Wang, Zhiwei
    Xin, Jianjun
    Kong, Biao
    Xu, Jing
    Zhang, Lei
    Chen, Pu
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2022, 8 (08) : 3515 - 3525
  • [10] Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients
    Geevimaan, Khamushavalli
    Guo, Jing-You
    Shen, Chia-Ning
    Jiang, Jeng-Kai
    Fann, Cathy S. J.
    Hwang, Ming-Jing
    Shui, Jr-Wen
    Lin, Hsiu-Ting
    Wang, Mei-Jung
    Shih, Hsuan-Cheng
    Li, Anna Fen-Yau
    Chang, Shih-Ching
    Yang, Shung-Haur
    Chen, Jeou-Yuan
    FRONTIERS IN ONCOLOGY, 2022, 12